ibrutinib,rituximab
abbvie,janssen
['thanks']
 thanks - i was still impressed! tho i may have missed the af data.
what do you make of the ki67 scores with regard to disease indolence / phenotype? #ash22
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer